Mueller, Jan
Karrasch, Stefan
Lorbeer, Roberto
Ivanovska, Tatyana
Pomschar, Andreas
Kunz, Wolfgang G.
von Krüchten, Ricarda
Peters, Annette
Bamberg, Fabian
Schulz, Holger
Schlett, Christopher L.
Article History
Received: 21 May 2018
Revised: 26 June 2018
Accepted: 12 July 2018
First Online: 27 August 2018
Compliance with ethical standards
:
: The scientific guarantor of this publication is Christopher L. Schlett, MD MPH.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional review board approval was obtained.
: Some study subjects or cohorts have been previously reported in Bamberg et al Subclinical disease burden as assessed by whole-body MRI in subjects with prediabetes, subjects with diabetes, and normal control subjects from the general population: the KORA-MRI study. Diabetes. 2017 Jan;66(1):158–169.
: • prospective• cross-sectional study/observational• performed at one institution